Results 181 to 190 of about 18,687 (213)

Darunavir/ritonavir

Reactions Weekly, 2017
  +5 more sources

Cobicistat/darunavir

Reactions Weekly, 2019
openaire   +2 more sources

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

Pharmacological Research, 2012
Dario Cattaneo, Cristina Gervasoni, Sara Baldelli   +2 more
exaly  

Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers

Journal of Clinical Pharmacology, 2014
Thomas N Kakuda
exaly  

Darunavir

2013
openaire   +1 more source

Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV

Journal of Antimicrobial Chemotherapy, 2020
Gary Maartens, Lübbe Wiesner, Catherine Orrell   +2 more
exaly  

Darunavir

Drugs, 2012
exaly   +2 more sources

HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies

HIV Clinical Trials, 2017
Erkki Lathouwers, Eric Y Wong, Sareh Seyedkazemi   +2 more
exaly  

Pharmacokinetics, Efficacy, and Safety of Darunavir/Ritonavir 800/100 mg Once-Daily in Treatment-Naïve and -Experienced Patients

HIV Clinical Trials, 2008
Marta Boffito, Andrew Hill
exaly  

Darunavir/ritonavir

Reactions Weekly, 2018
openaire   +1 more source